The Italian Journal of Neurological Sciences

, Volume 3, Issue 4, pp 273–280 | Cite as

Lymphocyte populations in patients with myasthenia gravis. Influence of thymectomy and immunosuppressive drugs

  • Ippoliti G. 
  • Piccolo G. 
  • Lombardi M. 
  • Carnevale Maffé G. 
  • Cosi V. 
  • Pinelli P. 
Original Articles

Abstract

The T/B peripheral blood lymphocyte ratio was evaluated in 51 patients with myasthenia gravis by means of the rosette test and HTLA. Total T cells and T γ and Tμ.

Key-words

Myasthenia Gravis T cell B cell Thymectomy Immunosuppressive Drugs 

Sommario

In 51 pazienti affetti da miastenia gravis sono state valutate, mediante il test delle rosette ed un siero anti-T, le popolazioni linfocitarie T e B. I risultati dimostrano una diminuzione delle cellule T, dei Tγe dei Tμ.

La pregressa timectomia e/o il trattamento immunosoppressivo induce un aumento dei T linfociti HTLA positivi, mentre quelli E rosette positivi permangono a valori inferiori alla norma.

Questo differente comportamento può essere dovuto alla presenza in circolo di linfociti T in differenti stadi di maturazione.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Abdou N.I., Lisak R.P., Zweiman B., Abrahamsohn I., Penn A.S.The Thymus in myasthenia gravis: evidence for altered cell populations. N. Engl. J. Med. 291, 1271–1275, 1974PubMedCrossRefGoogle Scholar
  2. [2]
    Appel S.H., Elias S.B.Anti-acetylcholine receptor antibodies in myasthenia gravis.In:Plasmapheresis and the immunology of myasthenia gravis (P.C.DauEd.) Houghton Mifflin, Boston 52, 1979Google Scholar
  3. [3]
    Berrih S., Gaud C., Bach N.A., Le Brigand H., Binet J.P., Bach J.F.Evaluation of T cell subset in myasthenia gravis using anti-T cell monoclonal antibodies Clin. Exp. Immunol. 45, 1–8, 1981PubMedGoogle Scholar
  4. [4]
    Birnbaum G., Tsairis P.Suppressor lymphocytes in Myasthenia Gravis and effect of adult thymectomy. Ann. N.Y. Acad. Sci. 274, 527–535, 1976PubMedGoogle Scholar
  5. [5]
    Birnbaum G., Tsairis P.Thymic lymphocytes in myasthenia gravis. Ann. Neurol. 1, 331–333, 1977CrossRefPubMedGoogle Scholar
  6. [6]
    Boyum A.Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21 Suppl. 97, 77–89, 1968PubMedGoogle Scholar
  7. [7]
    Castleman B.The pathology of the thymus gland in myasthenia gravis. Ann. N.Y. Acad. Sci. 135, 496–505, 1966PubMedGoogle Scholar
  8. [8]
    Chiu U.C., Hsieh K.H., Hung T.P.Imbalances in T cell subpopulations in myasthenia gravis. J. Neurol. Sci. 52, 53–59, 1981CrossRefPubMedGoogle Scholar
  9. [9]
    Conti Tronconi B.M., Di Padova F., Morputti M., Missiroli A., Frattola L.Stimulation of lymphocytes by cholinergic receptor in myasthenia gravis. J. Neuropathol. Exp. Neurol. 36, 157–167, 1977PubMedGoogle Scholar
  10. [10]
    Conti Tronconi B.M., Fumagalli G., Scotti A., Brigonzi A., Sher E., Morgutti M., Clementi F.:Myasthenia Gravis: an example of receptor disease. In: Receptor for neurotransmitters and peptide hormones (Pepeu G., Kuhar M.J. and Enna S.J. Eds) Raven Press, New York, 473–479, 1980Google Scholar
  11. [11]
    Cuénoud S., Feltkamp T.E.W., Fulpius B.W., Costerhuis H.J.G.H.Antibodies to acetylcholine receptor in patients with thymoma but without myasihenia gravis. Neurology, 30, 201–203, 1980PubMedCrossRefGoogle Scholar
  12. [12]
    Drachman D.B.Myasthenia gravis. N. Engl. J. Med. 298, 136–142, 1978PubMedCrossRefGoogle Scholar
  13. [13]
    Fauci A.S.Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone harrow. Immunology 28. 669–680, 1975PubMedGoogle Scholar
  14. [14]
    Fischbach M., Lindstrom J., Talal N.Antibodies to polyadenylic acid in patients with myasthenia gravis. Clin. Exp. Immunol. 43, 73–79, 1980Google Scholar
  15. [15]
    Fudenberg H.H., Wybran J., Robbins D.T rosette-forming cells, cellular immunity and cancer. N. Engl. J. Med. 292, 475–476, 1975PubMedCrossRefGoogle Scholar
  16. [16]
    Howard F.M. Jr.Myasthenia gravis with onset after 65 years of age: a preliminary report. In: Plasmapheresis and the immunobiology of myasthenia gravis (P.C. Dau Ed.) Houghton Mifflin, Boston, 281, 1979Google Scholar
  17. [17]
    Itoyama Y., Kawanami S., Goto I., Kuroiwa Y.T and B lymphocytes in myasthenia gravis. Clin. Exp. Immunol. 37, 452–456, 1979PubMedGoogle Scholar
  18. [18]
    Kashkia K.P.,Maximov A.V.,Vasilyev V.N.,Shabanova L.F.Alterations of immune status of myasthenic patients of thymectomy. Abstracts 4th Int. Congress of Immunology of IUIS, Paris, 21–26 July, 1980Google Scholar
  19. [19]
    Koziner B., Block K.J., Perlo V.P.Distribution of peripheral blood latex-ingesting cells T and B cells in patients with myasthenia gravis. Ann. N.Y. Acad. Sci. 274, 411–420, 1976PubMedGoogle Scholar
  20. [20]
    Lindstrom J., Seybold M.E., Lemon V.A., Whittingham S., Drake D.D.Antibody to acetylcoline receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value. Neurology (Minneap.) 26, 1054–1059, 1976Google Scholar
  21. [21]
    Lisak R.P., Zweinam B., Phillips S.M.Thymic and peripheral blood T and B-cell level in myasthenia gravis. Neurology 28, 1298–1300, 1978PubMedGoogle Scholar
  22. [22]
    Moretta L., Ferrarini M., Mingari M.C., Moretta A., Webbs R.Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J. Immunol. 117, 2171–2174, 1976PubMedGoogle Scholar
  23. [23]
    Morgutti M., Conti Tronconi B.M., Sghirlanzoni A., Clemente F.Cellular immune response to acetylcholine receptor in myasthenia gravis. II Thymectomy and corticosteroids. Neurology 28, 266–272, 1979Google Scholar
  24. [24]
    Osserman K.E.Myasthenia gravis (Grune and Stratton Eds) New York, 79–80, 1958Google Scholar
  25. [25]
    Papatestas A.E., Genkins G., Horowitz S.H., Kornfeld P.Thymectomy in myasthenia gravis: pathologic, clinical and electrophysiologic correlations. Ann. N.Y. Acad. Sci. 274, 555–576, 1976PubMedGoogle Scholar
  26. [26]
    Patrick J., Lindstrom J.Autoimmune response to acetylcholine receptor. Science 180, 871–872, 1973PubMedGoogle Scholar
  27. [27]
    Piantelli M., Lauriola L., Carbone A., Evoli A., Tonali P., Musiani P.Subpopulations of T-lymphocytes in myasthenia gravis patients. Clin. Exp. Immunol. 36, 85–89, 1979PubMedGoogle Scholar
  28. [28]
    Richman D.P., Patrick J., Arnason B.G.W.Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N. Engl. J. Med. 294, 694–698, 1976PubMedCrossRefGoogle Scholar
  29. [29]
    Romagnani S., Maggi E., Biagiotti R., Giudizi G.M., Amadori A., Ricci M.Receptors for IgM: a feature of subpopulations of both T and B lymphocytes. Clin. Exp. Immunol. 32, 324–332, 1978PubMedGoogle Scholar
  30. [30]
    Rose J., Huant S.W., Mayer R.F.Immunologic studies on myasthenia gravis. Trans. Am. Neurol. Assoc. 100, 60–62, 1975PubMedGoogle Scholar
  31. [31]
    Russo L., Scoppetta C., Tonali P.Shifting of the T/B lymphocyte ratio in myasthenia gravis patients after thymectomy. Neurology (Minn.) 27, 642–645, 1977Google Scholar
  32. [32]
    Scadding G.K., Thomas H.C., Havard C.W.H.The immunological effects of thymectomy in myasthenia gravis. Clin. Exp. Immunol. 36, 205–213, 1979PubMedGoogle Scholar
  33. [33]
    Stjernsward J., Joandal M., Vanky F., Wigzell H., Sealy R.Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma Lancet1, 1352–1356, 1972CrossRefPubMedGoogle Scholar
  34. [34]
    Touraine J.L., Touraine F.Sérum hétérologue anti-cellules T humaines. I. Préparation et spécificité. Rev. Inst. Pasteur Lyon 6, 123–125, 1973Google Scholar
  35. [35]
    Touraine J.L., Touraine F., Kiszkiss D.F., Choi Y.S., Good R.A.Heterologous specific antiserum for identification of human T lymphocytes. Clin. Exp. Immunol. 16, 503–520, 1974Google Scholar
  36. [36]
    Touraine J.L., Hadden J.W., Good R.A.Sequential stage of human T lymphocytes differentiation. Proc. Nat. Acad. Sci. USA 74, 3414–3416, 1974Google Scholar
  37. [37]
    Van De Griend R.J.,Carreno M.,Van Doorn R.,Lenpers C.J.M.,Van Den Ende A.,Vijermans, Oosterhuis H.J.G.H.,Astaldi A.Changes in human T lymphocytes after thymectomy and during senescence. In press.Google Scholar
  38. [38]
    Verhaegen H., Decock W., De Cree J.D.The effects of azathioprine and levamisole on rosetteforming cells of healthy subjects and cancer patients. Clin. Exp. Immunol. 29, 311–315, 1977PubMedGoogle Scholar
  39. [39]
    Wijermans P., Oosterhuis H.J.G.H., Astaldi G.C.B., Schellekens P.Th.A., Astaldi A.Thymus-dependent serum factor in non thymectomized and thymectomized patients with myasthenia gravis. Clin. Immunol. Immunopathol. 16, 11–18, 1980CrossRefPubMedGoogle Scholar
  40. [40]
    Wijermans P., Oosterhuis J.H.G.H., Astaldi G.C.B., Schellekens P.Th.A., Astaldi A.Influence of adult thymectomy on immunocompetence in patients with my asthenia gravis. J. Immunol. 124, 1977–1982, 1980PubMedGoogle Scholar
  41. [41]
    Wybran J., Fudenberg H.H.Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J. Clin. Invest. 52, 1026–1032, 1973PubMedCrossRefGoogle Scholar
  42. [42]
    Wybran J., Fundenberg H.H.Human thymusderived rosette-forming cells: their role in immunocompetence and immunosurveillance. In: Lymphocytes and their interactions. (Williams R.C. Jr. Ed.) Raven Press, N.Y., 113–122, 1975Google Scholar

Copyright information

© Masson Italia Editori S.p.A. 1982

Authors and Affiliations

  • Ippoliti G. 
    • 1
  • Piccolo G. 
    • 2
  • Lombardi M. 
    • 2
  • Carnevale Maffé G. 
    • 1
  • Cosi V. 
    • 2
  • Pinelli P. 
    • 3
  1. 1.Clinica Medica I “A. Ferrata” dell'Università di PaviaItalia
  2. 2.Clinica Neurologica dell'Università di PaviaItalia
  3. 3.Clinica Neurologica I dell'Università di MilanoItalia

Personalised recommendations